Company attributes
Location
B2X
Pitchbook URL
Legal Name
Matinas Biopharma, Inc.
Date Incorporated
2013
Number of Employees (Ranges)
11 – 50
Email Address
info@matinasbiopharma.com0
info@vstocktransfer.com0
peter.vozzo@westwicke.com0
Phone Number
+121282884360
+144321305050
+190848488050
Full Address
Center of Excellence, Building L-3 1025 Route 202/206, 3rd Floor Bridgewater, NJ 088070
1545 US Highway 206 Ste 302 Bedminster, NJ, 07921-2560 United States0
18 Lafayette Place Woodmere, NY 115980
CIK Number
Total Funding Amount (USD)
44,400,000
Latest Funding Round Date
November 2020
Stock Symbol
MTNB0
Exchange
Former CEO
Latest Funding Type
Patents Assigned (Count)
4
Country
Other attributes
Company Operating Status
Active
Ticker Symbol
MTNB
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, LYPDISO™ (MAT9001), for the treatment of cardiovascular and metabolic conditions.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
